Načítá se...
Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with a grim overall 5-year survival rate of 5%. Advances in surgical techniques, critical care, molecular diagnosis, diagnostic imaging, endosonology and adjuvant therapy have improved outcomes; but still more needs to be...
Uloženo v:
| Vydáno v: | World J Gastrointest Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4309949/ https://ncbi.nlm.nih.gov/pubmed/25685272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v7.i2.6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|